Regulation and modulation of PTEN activity

[1]  Hiroki Nakanishi,et al.  PTEN Regulates PI(3,4)P2 Signaling Downstream of Class I PI3K , 2017, Molecular cell.

[2]  Yuxin Yin,et al.  PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription , 2017, Nature Communications.

[3]  K. Shokat,et al.  INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC , 2017, Molecular Cancer Research.

[4]  N. Leslie,et al.  Controlling PTEN (Phosphatase and Tensin Homolog) Stability , 2016, The Journal of Biological Chemistry.

[5]  P. Hawkins,et al.  Emerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K-regulated pathways. , 2016, Biochemical Society transactions.

[6]  A. Marshall,et al.  Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling. , 2015, Cellular signalling.

[7]  Yuan Zhang,et al.  Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis , 2015, Nature Cell Biology.

[8]  P. Pinton,et al.  Study of PTEN subcellular localization , 2015, Methods.

[9]  R. Parsons,et al.  Molecular Pathways: Intercellular PTEN and the Potential of PTEN Restoration Therapy , 2014, Clinical Cancer Research.

[10]  Yuxin Yin,et al.  PTENα, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism. , 2014, Cell metabolism.

[11]  Kevin P. White,et al.  SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. , 2014, Cancer cell.

[12]  Saverio Marchi,et al.  The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. , 2014, Biochimica et biophysica acta.

[13]  J. Cheville,et al.  CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy. , 2014, Cancer research.

[14]  洪明奇.  Deubiquitination and stabilization of PTEN by USP13 , 2013 .

[15]  V. Uversky,et al.  The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy. , 2013, Molecular bioSystems.

[16]  C. Maier,et al.  PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism. , 2013, Journal of hepatology.

[17]  B. Cullen,et al.  MicroRNA‐17∼92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways , 2013, The EMBO journal.

[18]  K. Dutton-Regester,et al.  MC1R is a potent regulator of PTEN after UV exposure in melanocytes. , 2013, Molecular cell.

[19]  Jennifer S. Yu,et al.  Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress , 2013, Science.

[20]  P. Devreotes,et al.  Phosphorylation-mediated PTEN conformational closure and deactivation revealed with protein semisynthesis , 2013, eLife.

[21]  Soo Young Lee,et al.  PTEN regulation by the Akt/GSK-3β axis during RANKL signaling. , 2013, Bone.

[22]  P. Pandolfi,et al.  Identification of PTEN at the ER and MAMs and its regulation of Ca2+ signaling and apoptosis in a protein phosphatase-dependent manner , 2013, Cell Death and Differentiation.

[23]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[24]  W. Gu,et al.  RFP-mediated ubiquitination of PTEN modulates its effect on AKT activation , 2013, Cell Research.

[25]  Alfonso Bellacosa,et al.  A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival , 2013 .

[26]  J. Silke,et al.  The Tumor Suppressor PTEN Is Exported in Exosomes and Has Phosphatase Activity in Recipient Cells , 2012, Science Signaling.

[27]  Yan Qu,et al.  SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines , 2012, Neuroscience Letters.

[28]  Melanie A. Huntley,et al.  Recurrent R-spondin fusions in colon cancer , 2012, Nature.

[29]  M. Delepierre,et al.  Interference with the PTEN-MAST2 Interaction by a Viral Protein Leads to Cellular Relocalization of PTEN , 2012, Science Signaling.

[30]  P. Pinton,et al.  Mitochondrial Ca2+ and apoptosis , 2012, Cell calcium.

[31]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[32]  P. Pinton,et al.  Selective modulation of subtype III IP3R by Akt regulates ER Ca2+ release and apoptosis , 2012, Cell Death and Disease.

[33]  M. Ghosh,et al.  The Chaperone-assisted E3 Ligase C Terminus of Hsc70-interacting Protein (CHIP) Targets PTEN for Proteasomal Degradation* , 2012, The Journal of Biological Chemistry.

[34]  Xiaoqun Zhang,et al.  Functional analysis of the protein phosphatase activity of PTEN , 2012, The Biochemical journal.

[35]  G. Barton,et al.  PTEN Protein Phosphatase Activity Correlates with Control of Gene Expression and Invasion, a Tumor-Suppressing Phenotype, But Not with AKT Activity , 2012, Science Signaling.

[36]  L. Trotman,et al.  Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia , 2012, The Journal of cell biology.

[37]  Jian Zhang,et al.  SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane , 2012, Nature Communications.

[38]  K. Aldape,et al.  PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma , 2011, Oncogene.

[39]  Carlotta Giorgi,et al.  Calcium signaling around Mitochondria Associated Membranes (MAMs) , 2011, Cell Communication and Signaling.

[40]  A. Knudson,et al.  A continuum model for tumour suppression , 2011, Nature.

[41]  G. Baillie,et al.  Distinct functional outputs of PTEN signalling are controlled by dynamic association with β‐arrestins , 2011, The EMBO journal.

[42]  H. Broxmeyer,et al.  SIRT1 deficiency downregulates PTEN/JNK/FOXO1 pathway to block reactive oxygen species-induced apoptosis in mouse embryonic stem cells. , 2011, Stem cells and development.

[43]  J. Sarkaria,et al.  WWP2 is an E3 ubiquitin ligase for PTEN , 2011, Nature Cell Biology.

[44]  D. Tang,et al.  α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells. , 2011, Nature communications.

[45]  Masahiro Nakagawa,et al.  Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. , 2011, Blood.

[46]  K. Hogue,et al.  Protein Interactions of Phosphatase and Tensin Homologue (PTEN) and Its Cancer-associated G20E Mutant Compared by Using Stable Isotope Labeling by Amino Acids in Cell Culture-based Parallel Affinity Purification* , 2011, The Journal of Biological Chemistry.

[47]  Pier Paolo Pandolfi,et al.  Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner , 2011, Cell.

[48]  P. Pandolfi,et al.  PML Regulates Apoptosis at Endoplasmic Reticulum by Modulating Calcium Release , 2010, Science.

[49]  Jiahuai Han,et al.  Molecular and Cellular Pathobiology the Mir-17-92 Cluster of Micrornas Confers Tumorigenicity by Inhibiting Oncogene-induced Senescence , 2022 .

[50]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[51]  U. Suter,et al.  Dlg1-PTEN Interaction Regulates Myelin Thickness to Prevent Damaging Peripheral Nerve Overmyelination , 2010, Science.

[52]  G. Stephanopoulos,et al.  The Phosphoinositide 3-Kinase Regulatory Subunit p85 Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling , 2010 .

[53]  D. Tang,et al.  Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. , 2010, The Journal of clinical investigation.

[54]  Hiroki Takahashi,et al.  IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. , 2010, The Journal of surgical research.

[55]  Pier Paolo Pandolfi,et al.  Subtle variations in Pten dose determine cancer susceptibility , 2010, Nature Genetics.

[56]  M. D. Chamberlain,et al.  Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase , 2010, Proceedings of the National Academy of Sciences.

[57]  C. Downes,et al.  Ubiquitination of PTEN (Phosphatase and Tensin Homolog) Inhibits Phosphatase Activity and Is Enhanced by Membrane Targeting and Hyperosmotic Stress* , 2010, The Journal of Biological Chemistry.

[58]  C. Holt,et al.  E3 Ligase Nedd4 Promotes Axon Branching by Downregulating PTEN , 2010, Neuron.

[59]  M. Malumbres,et al.  The anaphase-promoting complex/cyclosome (APC/C): cell-cycle-dependent and -independent functions. , 2010, Biochemical Society transactions.

[60]  F. Cross,et al.  The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression , 2010, Oncogene.

[61]  J. Carethers,et al.  TGF- β mediates PTEN suppression and cell motility through calcium-dependent PKC- α activation in pancreatic cancer cells , 2010 .

[62]  T. Taira,et al.  Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. , 2009, International journal of oncology.

[63]  Barry Fine,et al.  Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a , 2009, Science.

[64]  R. Hindges,et al.  MyosinV controls PTEN function and neuronal cell size , 2009, Nature Cell Biology.

[65]  W. Sellers,et al.  p85 Associates with Unphosphorylated PTEN and the PTEN-Associated Complex , 2009, Molecular and Cellular Biology.

[66]  V. Leblanc,et al.  X-linked Inhibitor of Apoptosis Protein (XIAP) Regulates PTEN Ubiquitination, Content, and Compartmentalization* , 2009, The Journal of Biological Chemistry.

[67]  N. Leslie,et al.  Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity , 2009, The EMBO journal.

[68]  Yiling Lu,et al.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function. , 2009, Cancer cell.

[69]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[70]  T. Mustelin,et al.  PTEN regulation by Akt–EGR1–ARF–PTEN axis , 2009, The EMBO journal.

[71]  P. Pinton,et al.  Akt kinase reducing endoplasmic reticulum Ca2+ release protects cells from Ca2+-dependent apoptotic stimuli. , 2008, Biochemical and biophysical research communications.

[72]  Y. Yin,et al.  PTEN: a new guardian of the genome , 2008, Oncogene.

[73]  R. Parsons,et al.  The role of PTEN signaling perturbations in cancer and in targeted therapy , 2008, Oncogene.

[74]  Bin Zhao,et al.  PTEN acetylation modulates its interaction with PDZ domain. , 2008, Cancer research.

[75]  Pier Paolo Pandolfi,et al.  The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network , 2008, Nature.

[76]  V. Stambolic,et al.  The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization , 2008, Proceedings of the National Academy of Sciences.

[77]  Pier Paolo Pandolfi,et al.  Tenets of PTEN Tumor Suppression , 2008, Cell.

[78]  Roger A. Davis,et al.  Txnip balances metabolic and growth signaling via PTEN disulfide reduction , 2008, Proceedings of the National Academy of Sciences.

[79]  M. Bootman,et al.  Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis , 2008, Proceedings of the National Academy of Sciences.

[80]  C. Eng,et al.  The nuclear affairs of PTEN , 2008, Journal of Cell Science.

[81]  A. Gericke,et al.  PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes. , 2008, Biochemistry.

[82]  J. Yim,et al.  The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death , 2007, Cell Death and Differentiation.

[83]  Govind Bhagat,et al.  Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia , 2007, Nature Medicine.

[84]  A. Chan,et al.  Regulation of PTEN Activity by Its Carboxyl-terminal Autoinhibitory Domain* , 2007, Journal of Biological Chemistry.

[85]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[86]  Helene Maccario,et al.  PTEN is destabilized by phosphorylation on Thr366. , 2007, The Biochemical journal.

[87]  B. Vanhaesebroeck,et al.  The p110δ isoform of PI 3‐kinase negatively controls RhoA and PTEN , 2007 .

[88]  O. Lorenzo,et al.  Differential redox regulation within the PTP superfamily. , 2007, Cellular signalling.

[89]  Hong Wu,et al.  Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. , 2007, Cancer cell.

[90]  P. Vogt,et al.  A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth , 2007, Oncogene.

[91]  K. Sabapathy,et al.  c-Jun promotes cellular survival by suppression of PTEN , 2007, Cell Death and Differentiation.

[92]  Tom Misteli,et al.  Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression , 2007, Cell.

[93]  S. Baker.  PTEN Enters the Nuclear Age , 2007, Cell.

[94]  P. Pandolfi,et al.  Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity , 2007, Cell.

[95]  P. Pandolfi,et al.  NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN , 2007, Cell.

[96]  F. E. Bertrand,et al.  CBF-1 (RBP-Jk) Binds to the PTEN Promoter and Regulates PTEN Gene Expression , 2007, Cell cycle.

[97]  W. Yung,et al.  Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NFκB-dependent Pathway* , 2006, Journal of Biological Chemistry.

[98]  C. Eng,et al.  Nuclear localization of PTEN is regulated by Ca(2+) through a tyrosil phosphorylation-independent conformational modification in major vault protein. , 2006, Cancer research.

[99]  C. Downes,et al.  Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression , 2006, Journal of Cell Science.

[100]  M. Murakami,et al.  Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation. , 2006, Molecular biology of the cell.

[101]  R. DePinho,et al.  PCAF Modulates PTEN Activity*♦ , 2006, Journal of Biological Chemistry.

[102]  A. Andres-Pons,et al.  Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. , 2006, Molecular biology of the cell.

[103]  Arne Gericke,et al.  Regulation of the PTEN phosphatase. , 2006, Gene.

[104]  Tushar Patel,et al.  Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.

[105]  J. Coselli,et al.  Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin Signaling , 2006, Journal of Biological Chemistry.

[106]  W. Sellers,et al.  Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Yoko Takahashi,et al.  PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling , 2006, The EMBO journal.

[108]  B. Ahlemeyer,et al.  PTEN: A crucial mediator of mitochondria-dependent apoptosis , 2006, Apoptosis.

[109]  Tomas Mustelin,et al.  Cooperative Phosphorylation of the Tumor Suppressor Phosphatase and Tensin Homologue (PTEN) by Casein Kinases and Glycogen Synthase Kinase 3β* , 2005, Journal of Biological Chemistry.

[110]  R. B. Campbell,et al.  PTEN enters the nucleus by diffusion , 2005, Journal of cellular biochemistry.

[111]  F. E. Bertrand,et al.  Increased Protein Expression of the PTEN Tumor Suppressor in the Presence of Constitutively Active Notch-1 , 2005, Cell cycle.

[112]  S. Antonarakis,et al.  Binding of PTEN to Specific PDZ Domains Contributes to PTEN Protein Stability and Phosphorylation by Microtubule-associated Serine/Threonine Kinases* , 2005, Journal of Biological Chemistry.

[113]  A. Reymond,et al.  LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. , 2005, Human molecular genetics.

[114]  N. Tonks.  Redox Redux: Revisiting PTPs and the Control of Cell Signaling , 2005, Cell.

[115]  C. Eng,et al.  Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. , 2005, Cancer research.

[116]  Rong Zeng,et al.  Regulation of PTEN by Rho small GTPases , 2005, Nature Cell Biology.

[117]  Mariano Provencio,et al.  Promoter methylation of the PTEN gene is a common molecular change in breast cancer , 2004, Genes, chromosomes & cancer.

[118]  C. Compton,et al.  Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. , 2004, Cancer research.

[119]  Francisca Vazquez,et al.  Novel Mechanism of PTEN Regulation by Its Phosphatidylinositol 4,5-Bisphosphate Binding Motif Is Critical for Chemotaxis* , 2004, Journal of Biological Chemistry.

[120]  I. Batty,et al.  The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. , 2004, The Biochemical journal.

[121]  Kap-Seok Yang,et al.  Redox regulation of PTEN and protein tyrosine phosphatases in H2O2‐mediated cell signaling , 2004, FEBS letters.

[122]  J. Fata,et al.  Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland* , 2003, Journal of Biological Chemistry.

[123]  R. B. Campbell,et al.  Allosteric Activation of PTEN Phosphatase by Phosphatidylinositol 4,5-Bisphosphate* , 2003, Journal of Biological Chemistry.

[124]  Hong Wu,et al.  PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. , 2003, Cancer cell.

[125]  C. Eng,et al.  Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. , 2003, Cancer research.

[126]  William Arbuthnot Sir Lane,et al.  Direct identification of PTEN phosphorylation sites , 2002, FEBS letters.

[127]  Woojin Jeong,et al.  Reversible Inactivation of the Tumor Suppressor PTEN by H2O2 * , 2002, The Journal of Biological Chemistry.

[128]  C. Eng,et al.  Protean PTEN: form and function. , 2002, American journal of human genetics.

[129]  C. Downes,et al.  PTEN: The down side of PI 3-kinase signalling. , 2002, Cellular signalling.

[130]  H. Lee,et al.  Promoter Methylation and Silencing of PTEN in Gastric Carcinoma , 2002, Laboratory Investigation.

[131]  William R. Sellers,et al.  Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein Complex* , 2001, The Journal of Biological Chemistry.

[132]  T. Mustelin,et al.  The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling , 2001, Nature Cell Biology.

[133]  T. Mak,et al.  Regulation of PTEN transcription by p53. , 2001, Molecular cell.

[134]  K. Tsuchida,et al.  Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383. , 2001, Cancer research.

[135]  I. Pass,et al.  Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN , 2001, Current Biology.

[136]  Michael P. Myers,et al.  PTEN controls tumor-induced angiogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[137]  E. Eisenberg,et al.  Expression of auxilin or AP180 inhibits endocytosis by mislocalizing clathrin: evidence for formation of nascent pits containing AP1 or AP2 but not clathrin. , 2001, Journal of cell science.

[138]  R. Pulido,et al.  The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus , 2001, The Journal of Biological Chemistry.

[139]  P Komminoth,et al.  Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. , 2000, The American journal of pathology.

[140]  Francisca Vazquez,et al.  Phosphorylation of the PTEN Tail Regulates Protein Stability and Function , 2000, Molecular and Cellular Biology.

[141]  J. Yeh,et al.  Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. , 2000, The American journal of pathology.

[142]  C. Ross,et al.  Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[143]  Tomohiko Maehama,et al.  Crystal Structure of the PTEN Tumor Suppressor Implications for Its Phosphoinositide Phosphatase Activity and Membrane Association , 1999, Cell.

[144]  Kenneth M. Yamada,et al.  Shc and Fak Differentially Regulate Cell Motility and Directionality Modulated by Pten , 1999, The Journal of cell biology.

[145]  Toshinori Yoshida,et al.  Evidence That a Phosphatidylinositol 3,4,5-Trisphosphate-binding Protein Can Function in Nucleus* , 1999, The Journal of Biological Chemistry.

[146]  M. Wigler,et al.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[147]  José Luis de la Pompa,et al.  Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.

[148]  Kenneth M. Yamada,et al.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. , 1998, Science.

[149]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[150]  M. Wigler,et al.  P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[151]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[152]  J. Holik,et al.  Signaling by Phosphoinositide-3,4,5-Trisphosphate Through Proteins Containing Pleckstrin and Sec7 Homology Domains , 1997, Science.

[153]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[154]  M. Andjelkovic,et al.  High Affinity Binding of Inositol Phosphates and Phosphoinositides to the Pleckstrin Homology Domain of RAC/Protein Kinase B and Their Influence on Kinase Activity* , 1997, The Journal of Biological Chemistry.

[155]  L. Cantley,et al.  Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity , 1996, Molecular and cellular biology.

[156]  S. Lo,et al.  Tensin: A potential link between the cytoskeleton and signal transduction , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.